BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ER, estrogen receptor AND Diagnosis
227 results:

  • 1. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian cancer.
    Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
    JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mesonephric-like adenocarcinoma of the ovary.
    Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
    J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines.
    Anania S; Farnir M; Peiffer R; Boumahd Y; Thiry M; Agirman F; Maloujahmoum N; Bellahcène A; Peulen O
    Cell Commun Signal; 2024 Feb; 22(1):133. PubMed ID: 38368370
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
    Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
    World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High-grade HER2-positive mucoepidermoid carcinoma of the breast: a case report and review of the literature.
    Mura MD; Clement C; Foschini MP; Vander Borght S; Waumans L; Van Eyken P; Hauben E; Keupers M; Weltens C; Smeets A; Nevelsteen I; Floris G
    J Med Case Rep; 2023 Dec; 17(1):527. PubMed ID: 38062474
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Liver Mass as First-Time diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
    Kamashki A; Rivera M; Sturgis CD
    Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations.
    Dumitriu-Stan RI; Burcea IF; Nastase VN; Ceaușu RA; Dumitrascu A; Cocosila LC; Bastian A; Zurac S; Raica M; Poiana C
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003353
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
    Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
    Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pre-diagnosis Pain in Patients With Pancreatic cancer Signals the Need for Aggressive Symptom Management.
    McNearney TA; Digbeu BDE; Baillargeon JG; Ladnier D; Rahib L; Matrisian LM
    Oncologist; 2023 Dec; 28(12):e1185-e1197. PubMed ID: 37285228
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Male Accessory Breast cancer Successfully Treated With Single-Agent Trastuzumab: A Case Report.
    Ji W; Guo W
    Am J Mens Health; 2023; 17(3):15579883231171010. PubMed ID: 37218572
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment.
    Malavasi E; Giamas G; Gagliano T
    Cancer Gene Ther; 2023 Jul; 30(7):932-935. PubMed ID: 37085602
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
    Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
    J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
    Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
    Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer.
    Gao H; Huang J; Dai Q; Su J
    Arch Endocrinol Metab; 2023 Mar; 67(2):197-205. PubMed ID: 36651706
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel defined risk signature of endoplasmic reticulum stress-related genes for predicting the prognosis and immune infiltration status of ovarian cancer.
    Mo J; Ruan S; Yang B; Jin Y; Liu K; Luo X; Jiang H
    J Zhejiang Univ Sci B; 2023 Jan; 24(1):64-77. PubMed ID: 36632751
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinicopathologic Review of Metastatic Breast cancer to the Gynecologic Tract.
    Braun A; Reddy S; Cheng L; Gattuso P; Yan L
    Int J Gynecol Pathol; 2023 Jul; 42(4):414-420. PubMed ID: 36563298
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Application of dual-source computed tomography in the diagnosis of thyroid cancer and evaluation of biological behaviors.
    Wu W; Fang X; Li J; Zhang A; Zou Y; Zheng X
    J Clin Ultrasound; 2023 Jan; 51(1):195-202. PubMed ID: 36539919
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evolution of suppressing TSH therapy at diagnosis and in the long-term follow-up in a cohort of differentiated thyroid cancer.
    Díaz-Soto G; Fernández-Velasco P; Torres Torres B; López Gómez JJ; García Calvo S; de Luis Román D
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Dec; 69(10):844-851. PubMed ID: 36470820
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
    Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
    Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical characteristics of patients with Breast and / or Ovarian cancer with mutations in the BRCA1 and BRCA2 genes in Córdoba, Argentina].
    Martin CA; Suárez Villasmil L; Sembaj A; Gomez Balangione F; Zunino S; Montes CDC; Borello A; Del Castillo A; Zeballos M; Rossi NT
    Rev Fac Cien Med Univ Nac Cordoba; 2022 Sep; 79(3):228-234. PubMed ID: 36149077
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.